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Mutants	   of	   the	   wheat	   pathogenic	   fungus	   Stagonospora	   nodorum	   lacking	   G-­‐protein	  22	  
subunits	   display	   a	   variety	   of	   phenotypes	   including	   melanisation	   defects,	   primary	  23	  
metabolic	  changes	  and	  a	  decreased	  ability	  to	  sporulate.	  To	  better	  understand	  the	  causes	  24	  
of	   these	   phenotypes,	   Stagonospora	  nodorum	   strains	   lacking	   a	   Gα,	   Gβ	   or	   a	   Gγ	   subunit	  25	  
were	   compared	   to	   a	  wild-­‐type	   strain	   using	  metabolomics.	   Agar	   plate	   growth	   at	   22°C	  26	  
revealed	   a	   number	   of	   fundamental	  metabolic	   changes	   and	   highlighted	   the	   influential	  27	  
role	  of	   these	  proteins	   in	   glucose	  utilisation.	  A	   further	   characterisation	  of	   the	  mutants	  28	  
was	   undertaken	   during	   prolonged	   storage	   at	   4°C;	   conditions	   known	   to	   induce	  29	  
sporulation	  in	  these	  sporulation-­‐deficient	  signalling	  mutants.	  The	  abundance	  of	  several	  30	  
compounds	   positively	   correlated	   with	   the	   onset	   of	   sporulation	   including	   the	  31	  
dissacharide	   trehalose,	   the	   tryptophan	   degradation	   product	   tryptamine	   and	   the	  32	  
secondary	   metabolite	   alternariol;	   metabolites	   all	   previously	   associated	   with	  33	  
sporulation.	   Several	   other	   compounds	   decreased	   or	   were	   absent	   during	   sporulation.	  34	  
The	   levels	  of	  one	  such	  compound,	   (Unknown_35.27_2194_319),	  decreased	   from	  being	  35	  
one	   of	   the	   more	   abundant	   compounds	   to	   absence	   during	   pycnidial	   maturation.	   This	  36	  
study	  has	   shed	   light	   on	   the	   role	  of	  G-­‐protein	   subunits	   on	  primary	  metabolism	  during	  37	  
vegetative	   growth	   and	   exploited	   the	   cold-­‐induced	   sporulation	   phenomomen	   in	   these	  38	  
mutants	   to	   identify	   some	   key	   metabolic	   changes	   that	   occur	   during	   asexual	  39	  
reproduction.	  40	  
	  41	  
	   	  42	  
INTRODUCTION	  43	  
Stagonospora	  nodorum	   is	   a	   filamentous	   fungus	   and	   the	   causal	   agent	   of	   stagonospora	  44	  
nodorum	  blotch	  (SNB)	  on	  wheat	  (Solomon	  et	  al.,	  2006a).	  It	  is	  a	  necrotrophic	  pathogen	  45	  
that	  relies	  on	  the	  secretion	  of	  small,	  secreted	  proteinaceous	  effectors	  to	  cause	  disease	  in	  46	  
an	   inverse	   gene-­‐for-­‐gene	   manner	   (Oliver	   &	   Solomon,	   2010).	   Recent	   reverse	   genetic	  47	  
approaches	  have	   identified	  many	  genes,	  proteins,	  pathways	  and	  metabolites	   that	  play	  48	  
important	  roles	  in	  enabling	  S.	  nodorum	  to	  complete	  its	  pathogenic	  lifecycle	  (Oliver	  et	  al.,	  49	  
2012).	  	  50	  
One	   aspect	   of	   the	   disease	   that	   has	   received	   considerable	   attention	   has	   been	   signal	  51	  
transduction,	   and	   in	   particular,	   cAMP-­‐dependent	   signalling.	   Mutants	   of	   S.	   nodorum	  52	  
harbouring	  inactive	  copies	  of	  a	  Gα	  (Gna1,	  Gα	  I	  class),	  a	  Gβ	  (Gba1)	  or	  a	  Gγ	  (Gga1)	  subunit	  53	  
were	  all	  only	  weakly	  pathogenic	  at	  best	  and	  displayed	  a	  number	  of	  other	  phenotypes	  in	  54	  
vitro	  including	  nitrogen	  utilisation	  deficiencies,	  impaired	  melanisation	  and	  a	  decrease	  in	  55	  
extracellular	   protease	   activity	   (Gummer	   et	   al.,	   2012;	   Solomon	   et	   al.,	   2004).	   Another	  56	  
phenotype	  common	  to	  mutants	  lacking	  either	  of	  the	  heterotrimeric	  G-­‐protein	  subunits	  57	  
listed	   above	  was	   a	   complete	   lack	   of	   sporulation,	   either	   in	  vitro	   or	   in	  planta.	   A	   recent	  58	  
study	   though	  by	  Gummer	  et	  al	   (2012)	  described	  how	  prolonged	   storage	   at	   4°C	   could	  59	  
induce	  sporulation	  in	  all	  of	  the	  mutants.	  After	  incubation	  at	  4°C	  for	  six	  weeks,	  pycnidia	  60	  
appeared	   containing	   viable	   pycnidiospores	   whilst	   no	   pycnidia	   differentiated	   after	  61	  
incubation	   at	   22°C	   for	   an	   equivalent	   time.	   The	   mechanism	   behind	   the	   cold-­‐induced	  62	  
sporulation	  is	  unknown.	  63	  
Proteomics	   approaches	   have	   been	   exploited	   to	   better	   understand	   the	   role	   of	   these	  64	  
signalling	  genes	   in	  disease	  and	  fungal	  development	  (Bringans	  et	  al.,	  2009;	  Casey	  et	  al.,	  65	  
2010;	   Tan	   et	   al.,	   2009a).	   Conventional	   two-­‐dimensional	   gel	   approaches	   along	   with	  66	  
quantitative	   liquid	   chromatography	  methods	  have	   identified	   several	   targets	   regulated	  67	  
by	   these	   G-­‐protein	   subunits	   in	   S.	   nodorum.	   	   For	   example,	   a	   comparative	   proteomic	  68	  
analysis	  of	  the	  gna1-­‐35	  strain	  identified	  that	  the	  Sch1	  protein	  was	  positively	  regulated	  69	  
by	  Gα	  signalling	  (Tan	  et	  al.,	  2008).	  Subsequent	  analysis	  of	   the	  S.	  nodorum	  sch1	  mutant	  70	  
strain	  revealed	  the	  massive	  accumulation	  of	  the	  mycotoxin	  alternariol.	  This	  was	  the	  first	  71	  
such	   identification	  of	   a	  mycotoxin	   in	  S.	  nodorum	   and	  highlighted	   the	  potential	  human	  72	  
health	  impact	  of	  SNB	  disease	  (Tan	  et	  al.,	  2009b).	  73	  
A	  complementary	  approach	  to	  study	  these	  mutants	  is	  metabolomics.	  Metabolomics	  is	  a	  74	  
non-­‐targeted	  method	  to	  relatively	  quantitate	  the	  metabolites	  present	  in	  a	  given	  sample	  75	  
at	  the	  time	  of	  sample	  harvest	  (Gummer	  et	  al.,	  2011;	  Kim	  et	  al.,	  2011).	  Metabolomics	  is	  76	  
an	   appropriate	   method	   with	   which	   to	   understand	   how	   cold	   storage	   triggers	   asexual	  77	  
sporulation	  as	  several	  studies	  in	  S.	  nodorum	  to	  date	  have	  highlighted	  the	  importance	  of	  78	  
primary	  metabolites	  in	  differentiation.	  79	  
One	   such	   study	   identified	   that	  mannitol	  metabolism	  exists	   as	   two	   separate	  pathways,	  80	  
rather	  than	  the	  previously	  hypothesized	  single	  cycle	  (Solomon	  et	  al.,	  2005;	  Solomon	  et	  81	  
al.,	  2006c;	  Solomon	  et	  al.,	  2007).	  These	  studies	  showed	  that	  the	  inability	  of	  a	  S.	  nodorum	  82	  
mutant	   to	   sporulate	   was	   correlated	   with	   the	   depletion	   of	   the	   intracellular	   mannitol	  83	  
pool.	   Studies	   of	   the	  mpd1	   mutant	   strain,	   compromised	   in	   its	   ability	   to	   synthesise	   or	  84	  
grow	  on	  mannitol	  as	  a	  sole	  carbon	  source,	  established	  mannitol	  as	  playing	  an	  essential	  85	  
role	   in	   asexual	   sporulation	   in	   S.	   nodorum	  both	   in	   vitro	   and	   in	   planta	   (Solomon	   et	   al.,	  86	  
2006c).	  Interestingly	  in	  the	  mannitol-­‐depleted	  strain,	  the	  reduced	  intensity	  of	  mannitol	  87	  
in	   metabolite	   profiles	   appeared	   to	   be	   compensated	   by	   an	   increased	   abundance	   of	  88	  
trehalose.	  	  89	  
In	   a	   separate	   study	   by	   Lowe	   et	   al.,	   trehalose	   abundance	   was	   also	   linked	   to	   asexual	  90	  
sporulation	   in	   S.	   nodorum	   (Lowe	   et	   al.,	   2009).	   Trehalose	   synthesis	   was	   disrupted	   by	  91	  
deletion	  of	  a	  trehalose	  6-­‐phosphate	  synthase	  (Tps1)	  gene,	  with	  the	  resulting	  tps1	  strain	  92	  
possessing	  a	  reduced	  capacity	  to	  develop	  pycnidia,	  and	  failing	  to	  progress	  into	  asexual	  93	  
sporulation.	   Gas	   chromatography-­‐mass	   spectrometry	   (GC-­‐MS)	   analysis	   of	   metabolite	  94	  
extracts	   of	   the	   tps1	   strain	   showed	   a	   correlation	   between	   trehalose	   abundance	   and	  95	  
asexual	  sporulation	  both	  in	  vitro	  and	  in	  wheat	  (Lowe	  et	  al.,	  2009).	  96	  
The	   phenotypes	   of	   the	   S.	   nodorum	   gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25	   strains	   are	   of	  97	  
considerable	   interest,	  and	  provided	  an	  opportunity	   to	   link	  specific	  biochemical	  events	  98	  
to	   signalling	   in	   S.	   nodorum.	   Of	   particular	   interest	   is	   the	   resulting	   phenotype	   of	   the	  99	  
signalling	  mutants	  during	  prolonged	  cold	  storage	  and	  the	  opportunity	  they	  provide	  to	  100	  
further	   dissect	   asexual	   sporulation	   in	   S.	   nodorum.	   In	   this	   study,	   an	   untargeted	  101	  
metabolomic	  analysis	  was	  used	  to	  dissect	  the	  phenotypes	  of	  S.	  nodorum	  wild-­‐type	  strain	  102	  
SN15,	  and	   the	  changes	   that	  occurred	   to	   the	  metabolome	  as	  a	   result	  of	   the	   inactivated	  103	  
Gna1,	  Gba1	  and	  Gga1	  genes.	  104	  
105	  
METHODS	  106	  
Preparation	   of	   plate-­‐cultured	   S.	   nodorum	   for	   metabolite	   extraction.	   S.	   nodorum	   wild-­‐107	  
type	   SN15	   and	   strains	   gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25,	   were	   inoculated	   from	   minimal	  108	  
medium	  (30	  g	  l−1	  sucrose,	  2	  g	  l−1	  NaNO3−,	  1.0	  g	  l−1	  K2HPO4,	  0.5	  g	  l−1	  KCl,	  0.5	  g	  l−1	  MgSO4·109	  
7H2O,	   0.01	   g	   l−1	   ZnSO4·7H2O,	   0.01	   g	   l−1	   FeSO4·7H2O,	   0.0025	   g	   l−1	   CuSO4·5H2O)	   agar-­‐110	  
cultured	  mycelia,	  onto	  the	  centre	  of	  a	  sterile	  nitrocellulose	  filter	  (overlayed	  on	  minimal	  111	  
medium	   agar).	   The	   composition	   of	   minimal	   medium	   has	   been	   previously	   described	  112	  
(Solomon	  et	  al.,	  2006b).	  Cultures	  were	  grown	  with	  a	  12-­‐h	  white-­‐light	  regimen	  at	  22°C.	  113	  
For	   the	   simultaneous	   analysis	   of	   intracellular	   and	   extracellular	   metabolites,	   cultures	  114	  
were	  grown	   for	   five,	  eight	  or	  10	  days,	  with	  six	  replicates	  harvested	  per	  strain	  at	  each	  115	  
time	  point.	  For	  the	  analysis	  of	  intracellular	  metabolites,	  cultures	  were	  grown	  for	  five	  or	  116	  
10	  days,	  with	   six	   cultures	  harvested	  per	   strain	  at	   each	   time	  point.	   For	   the	  analysis	  of	  117	  
intracellular	  metabolites	  under	  asexually	   sporulating	   conditions,	   cultures	  were	  grown	  118	  
for	  five	  days	  then	  incubated	  at	  4°C	  for	  three	  or	  six	  weeks	  before	  harvesting.	  Six	  cultures	  119	  
were	  prepared	  per	  strain	  per	  time	  point.	  120	  
Fungal	   cultures	   were	   harvested	   by	   scraping	   the	   mycelia	   from	   the	   nitrocellulose	  121	  
(overlaying	   the	   growth	   medium)	   using	   a	   scalpel,	   or	   by	   transferring	   the	   entire	  122	  
nitrocellulose	   filter	   into	   a	   two	  ml	   safe-­‐lock	   microcentrifuge	   tube.	   Each	   replicate	   was	  123	  
harvested	   in	   less	  than	  10	  seconds.	  The	  samples	  were	  then	  dried	  by	   lyophilisation	   in	  a	  124	  
LABCONCO	   Freezone	   2.5	   Plus	   (©Labconco	   Corp.,	   USA)	   depressurized	   with	   a	   JLT-­‐10	  125	  
JAVAC	  high	  vacuum	  pump	  (JAVAC	  Pty.	  Ltd.,	  Australia).	  126	  
	  127	  
	  128	  
	  129	  
Metabolite	  extraction	  and	  isolation.	  Metabolites	  were	  extracted	  from	  between	  five	  and	  130	  
10	   mg	   dried	   mycelium.	   Fungal	   mycelia	   were	   transferred	   to	   a	   two	   ml	   safe-­‐lock	  131	  
microcentrifuge	   tube	   containing	   a	   three	   mm	   diameter	   ball	   bearing.	   To	   the	   tube	   was	  132	  
added	  685	  μl	  of	  -­‐40°C	  methanol	  and	  the	  tube	  shaken	  vigorously	  in	  a	  Retsch®	  MM301	  133	  
lyser	  (Retsch®,	  UK)	  at	  30	  (Htz;	  1/s)	  for	  two	  minutes.	  75	  μl	  of	  water	  containing	  1.25	  μ134	  
g	   ribitol	   (internal	   standard)	  was	  added	   to	   the	  suspension	  per	  one	  mg	  of	   fungal	   tissue	  135	  
and	   the	   tube	   returned	   to	   the	   tissue	   lyser	   for	   a	   further	   two	   minutes.	  For	   extractions	  136	  
containing	  nitrocellulose,	  the	  methanol	  and	  water	  were	  added	  together	  before	  shaking	  137	  
in	  the	  lyser.	  Following	  which,	  the	  tube	  was	  frozen	  in	  liquid	  nitrogen,	  and	  thawed	  on	  ice.	  138	  
After	   briefly	   mixing	   the	   suspension	   by	   vortexing,,	   cell	   debris	   were	   collected	   by	  139	  
centrifugation	  in	  an	  eppendorf	  5415R	  centrifuge	  (eppendorf,	  USA)	  at	  20,000	  g	   for	  two	  140	  
minutes.	  The	  supernatant	  was	  then	  transferred	  to	  a	  fresh	  microcentrifuge	  tube.	  250	  μl	  141	  
of	   -­‐40°C	  90%	  methanol	  was	  added	  to	  the	  remaining	  pellet	  and	  the	  tube	  shaken	   in	  the	  142	  
lyser	  for	  two	  minutes.	  The	  cell	  debris	  was	  again	  collected	  by	  centrifugation	  at	  20,000	  g	  143	  
for	  two	  minutes.	  The	  supernatant	  was	  added	  to	  the	  previous	  and	  the	  pellet	  discarded.	  144	  
The	  combined	  supernatant	  was	  vortexed	  and	  a	  two	  mg-­‐fungal-­‐tissue	  equivalent	  volume	  145	  
transferred	  to	  a	  fresh	  tube	  and	  dried	  in	  preparation	  for	  chemical	  derivatisation	  by;	  first	  146	  
removing	   the	   methanol	   by	   evaporation	   in	   an	   eppendorf	   Concentrator	   Plus	   vacuum	  147	  
concentrator	   (eppendorf,	   USA)	   before	   then	   freezing	   the	   remaining	   extract	   in	   liquid	  148	  
nitrogen	   and	   drying	   it	   in	   a	   LABCONCO	   Freezone	   2.5	   Plus	   (©Labconco	   Corp.,	   USA)	  149	  
depressurized	  with	  a	  JLT-­‐10	  JAVAC	  high	  vacuum	  pump	  (JAVAC	  Pty.	  Ltd.,	  Australia).	  150	  
	  151	  
	  152	  
MEOX-­‐TMS	   derivatisation	   of	   fungal	   metabolites	   for	   GC-­‐MS	   analysis.	   The	   dried	   fungal	  153	  
metabolites	  were	  derivatised	  by	  a	  combination	  of	  oximation	  and	  silylation	  reactions.	  To	  154	  
the	   dried	  metabolite	   extract	  was	   added	   20	  μl	   of	  methoxylamine	  HCl	   (Sigma-­‐Aldrich,	  155	  
Australia)	   [20mg/ml	   in	   pyridine	   (©UNIVAR)],	   followed	   by	   a	   brief	   vortex	   to	  mix	   and	  156	  
incubation	  in	  an	  eppendorf	  Thermomixer	  (Eppendorf,	  USA)	  at	  30°C	  for	  two	  hours	  with	  157	  
shaking	   at	   1250	   rpm.	   40	  μl	   MSTFA	   (©Thermo	   Fisher	   Scientific	   Inc.,	   USA)	   was	   then	  158	  
added,	   vortexed	   briefly	   to	  mix,	   and	   incubated	   at	   37°C	   for	   one	   hour	  whilst	   shaking	   at	  159	  
1250	  rpm.	  The	  derivatised	  product	  was	   then	   transferred	   to	  a	  200	  μl	  glass	  vial	   insert	  160	  
within	  a	  1.5	  ml	  amber	  vial	  (Grace	  Davison	  Discovery	  Sciences,	  Australia)	  and	  five	  μl	  of	  161	  
a	  mixture	   of	   alkanes	   (Retention	   index	   standard)	   added	   and	  mixed.	   The	   solution	  was	  162	  
then	   sealed	  within	   the	   vial	  with	   an	  11	  mm	  aluminium	  crimp	   cap	   seal	   (Grace	  Davison	  163	  
Discovery	  Sciences,	  Australia).	  	  164	  
	  165	  
GC-­‐MS	   analysis	   of	   fungal	   metabolite	   extracts.	   Derivatized	   metabolites	   (1	   µl)	   were	  166	  
injected	   into	   a	   split/splitless	   GC	   inlet	   using	   a	   20:1	   split	   injection	   mode,	   for	   GC-­‐MS	  167	  
analysis.	   The	   GC-­‐MS	   equipment	   consisted	   of	   an	   Agilent	   7680	   autosampler,	  an	   Agilent	  168	  
6890	   gas	   chromatograph,	   and	   an	   Agilent	   5973N	   quadrupole	   mass	   spectrometer	  169	  
(©Agilent,	   Palo	   Alto,	   CA,	   USA).	   The	   GC-­‐MS	   system	   was	   autotuned	   using	  170	  
perfluorotributylamine	  (PFTBA).	  A	  30-­‐m	  Varian	  VF-­‐5ms	  FactorFour	  column	  with	  a	  10-­‐171	  
m	   integrated	   Varian	   EZ-­‐Guard	   column	   was	   used	   (Varian,	   Palo	   Alto,	   CA,	   USA).	   The	  172	  
injection	  inlet	  temperature	  was	  230°C,	  with	  an	  interface	  temperature	  of	  300°C,	  and	  an	  173	  
ion	  source	  temperature	  of	  230°C.	  Helium	  was	  used	  as	  the	  carrier	  gas,	  and	  the	  flow	  rate	  174	  
was	  retention	  time	  locked	  to	  elute	  a	  derivatised	  mannitol	  standard	  at	  RT	  30.6	  minutes	  175	  
using	   the	   Chemstation	   (©Agilent,	   Palo	   Alto,	   CA,	   USA)	   software.	   The	   temperature	  176	  
gradient	  consisted	  of	  an	  initial	  temperature	  of	  70°C,	   increasing	  at	  1°C	  per	  minute	  for	  5	  177	  
min	  before	  increasing	  to	  a	  final	  hold	  temperature	  of	  300°C	  at	  a	  temperature	  ramp	  rate	  178	  
of	  5.6°C	  per	  minute	  with	  a	  transfer	  line	  temperature	  of	  330°C.	  179	  
	  180	  
Data	   processing	   and	   analysis.	   AnalyzerPro™	   (SpectralWorks	   Ltd.,	   Runcorn,	   United	  181	  
Kingdom)	   was	   used	   to	   deconvolute	   and	   library	   match	   the	   acquired	   mass	   spectra.	  182	  
Metabolite	  peak	  areas	  representing	  the	  abundance	  of	  the	  metabolites	  were	  normalized,	  183	  
and	   the	   data	   was	   cross-­‐referenced	   against	   the	   target	   component	   library	   using	   the	  184	  
MatrixAnalyser	   add-­‐on.	   Peaks	   that	   could	   not	   be	   matched	   to	   the	   target	   component	  185	  
library	  were	  described	   as	   unknown	  metabolites	   and	  were	   given	   a	  MST	  name	   labelled	  186	  
according	  to	  the	  following	  format:	  ‘Unknown_retention	  time_retention	  index_base	  peak’.	  187	  
Overloaded	  chromatographic	  peaks	  were	  re-­‐processed	  with	  the	  software	  and	  analytes	  188	  
quantified	   on	   a	   single	   ion	   determined	   not	   to	   be	   saturated	   when	   detected	   in	   the	   MS.	  189	  
Putative	  identifications	  were	  assigned	  to	  unknown	  metabolites	  using	  the	  Library	  Search	  190	  
function	  of	  AnalyzerPro™	  on	  the	  deconvoluted	  mass	  spectra,	  and	  the	  National	  Institute	  191	  
of	  Standards	  and	  Technology	  (NIST,	  USA)	  Mass	  Spectral	  Library.	  192	  
Data	   sets	  were	   exported	   from	  AnalyzerPro™	   for	   calculations	   and	   layout	  manipulation	  193	  
using	  Microsoft	  Excel.	  ‘Normalised’	  analyte	  abundances	  were	  calculated	  by	  dividing	  the	  194	  
determined	   analyte	   peak	   area	   by	   that	   determined	   for	   ribitol	   (internal	   standard).	   The	  195	  
determined	   analyte	   peak	   areas	   were	   then	   divided	   by	   the	  weight	   of	   the	   fungal	   tissue	  196	  
used	  in	  the	  extract.	  	  197	  
The	   scripting	   program	   Ruby	   was	   used	   to	   design	   and	   implement	   a	   script	   for	   the	  198	  
alignment	  of	  mass	  spectral	  peaks	  common	  across	   the	  generated	  data	  sets	   in	   the	  Ruby	  199	  
programming	   language.	  The	  script	  used	  the	  outputted	  AnalyzerPro™	  Summary	  Report	  200	  
to	  align	  all	  peaks	  eluting	  within	  0.05	  1/100ths	  of	  a	  minute,	   identified	  with	  a	  common	  201	  
base	   peak	   (m/z).	   The	   acquired	   data	   output	   was	   integrated	   with	   the	   AnalyzerPro™	  202	  
Matrix	  Analyzer	  output	  to	  produce	  the	  final	  metabolomic	  data	  set.	  	  	  	  203	  
Metabolomic	   datasets	   were	   subjected	   to	   principal	   component	   analysis	   (PCA;	   The	  204	  
Unscrambler®,	  CAMO	  Software,	  AS)	  using	  a	  Full-­‐Cross	  Validation,	  subsequent	  to	  scaling	  205	  
[x	  =	  log(x	  +	  1)]	  of	  the	  metabolite	  abundances.	  Figures	  were	  edited	  for	  visual	  purposes.	  206	  
Normalised	   metabolite	   abundances	   were	   analysed	   by	   Tukey	   Kramer	   analysis	   (JMP	  207	  
8.0.2®,	  SAS	  Institute)	  for	  a	  determination	  of	  statistical	  significance.	  	  208	  
209	  
Results	  210	  
	  211	  
Metabolome	  analysis	  of	  S.	  nodorum	  strains	  SN15,	  gna1-­‐35,	  gba1	  and	  212	  
gga1	  213	  
The	  intracellular	  metabolomes	  of	  S.	  nodorum	  strains	  SN15,	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25	  214	  
were	   analysed	   at	   both	   five	   and	   10	   days	   post	   inoculation	   (dpi).	   These	   time	   points	  215	  
represent	   earlier	   and	   later	   stages	   of	   growth.	   Tables	   1	   and	   2	   display	   the	   relative	  216	  
abundance	  of	   the	   identified	  metabolites	  determined	  to	  be	  differentially	  abundant	  (p	  <	  217	  
0.05)	   between	   at	   least	   one	   of	   gna1-­‐35,	   gba1-­‐6	   or	   gga1-­‐25	   and	   the	   wild-­‐type	   SN15.	  218	  
Differentially	   abundant	  unidentified	  metabolites	   are	   listed	   in	   Supplementary	  Tables	  1	  219	  
and	  2.	  220	  
At	  5	  dpi,	  many	  of	  the	  compounds	  that	  were	  differentially	  abundant	  in	  most	  or	  all	  of	  the	  221	  
mutants	  compared	   to	  SN15	  were	  sugars	  or	   sugar	  alcohols	   including	  glucose,	   fructose,	  222	  
glucopyranose	  and	  arabitol.	  Other	  compounds	  of	   interest	   that	  differed	   in	  the	  wildtype	  223	  
compared	  to	  the	  mutants	  included	  ornithine	  and	  also	  the	  mycotoxin	  alternariol.	  By	  10	  224	  
dpi,	   many	   of	   the	   sugars	   were	   no	   longer	   significantly	   different	   between	   the	   strains.	  225	  
Several	   organic	   acids	   though,	   such	   as	   succinic	   acid,	   fumaric	   acid,	   α-­‐ketoglutaric	   acid,	  226	  
malic	  acid	  and	  citric	  acid,	  were	  altered	  in	  abundance,	  particularly	  gga1-­‐25,	  compared	  to	  227	  
SN15.	  It	  was	  also	  notable	  that	  several	  amino	  acids	  differed	  in	  abundance,	  particularly	  in	  228	  
the	  gna1-­‐35	  and	  gga1-­‐25	  strains.	  229	  
The	   combined	   intracellular	   and	   extracellular	  metabolites	   of	   each	   of	   the	   strains	   were	  230	  
also	  examined.	  By	  comparing	  these	  data	  to	  the	  intracellular	  results	  above,	  we	  sought	  to	  231	  
identify	   and	   relatively	   quantitate	   compounds	   secreted	   in	   the	  mutants.	   This	   approach	  232	  
was	   chosen	   due	   to	   technical	   limitations	   impeding	   the	   direct	   measurement	   of	  233	  
extracellular	   metabolites	   using	   the	   nitrocellulose	   filter	   growth	   system.	   The	   PCA	   and	  234	  
loading	  scores	  plots	  are	  shown	  in	  Supplementary	  Fig.	  1	  and	  2.	  	  235	  
A	   comparison	   of	   the	   normalised	   intracellular	   mannitol	   abundances,	   with	   those	  236	  
determined	   for	   the	   combined	   intracellular	   and	   extracellular	   metabolite	   analysis	  237	  
revealed	  some	  significant	  discrepancies	  when	  comparing	  the	  wild-­‐type	  and	  the	  mutant	  238	  
strains	   (Fig.	   1).	  Whilst	   intracellular	  mannitol	  was	   significantly	   depleted	   between	   five	  239	  
and	  10	  dpi	  for	  the	  wild-­‐type	  SN15	  and	  mutant	  strain	  gba1-­‐6,	  there	  was	  an	  insignificant,	  240	  
if	  not	  opposite	  trend,	  for	  the	  combined	  intra/extracellular	  measurement	  of	  mannitol	  in	  241	  
these	   two	   strains	   over	   this	   time.	   This	   observation	   could	   be	   explained	   only	   by	   the	  242	  
presence	  of	  extracellular	  mannitol,	  and	  may	  suggest	  the	  secretion	  of	  this	  metabolite	  by	  243	  
some	  strains.	  	  	  244	  
The	  levels	  of	  glucose	  also	  differed	  significantly	  when	  comparing	  the	  intracellular	  to	  the	  245	  
combined	   intra/extracellular	   samples	   between	   the	   different	   strains	   (Fig.	   2).	   The	  246	  
abundance	   of	   Glucose	   (summed	   for	   the	   two	   chromatographic	   instances,	  247	  
5TMS_30.21_1884_319	   and	   5TMS	   30.39_1902_319)	   was	   determined	   to	   be	   4.59,	   5.00	  248	  
and	   3.75	   times	   less	   in	   gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25,	   respectively.	   Glucose	  249	  
5TMS_30.39_1902_319	  was	  4.25,	  4.18	  and	  3.50	  times	  less	  in	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐250	  
25,	   respectively.	   Although	   less	   in	   all	   mutant	   strains,	   at	   this	   time,	   glucose	   remained	  251	  
available	   in	   high	   abundance	   in	   the	   growth	   medium	   for	   both	   wild-­‐type	   and	   mutant	  252	  
strains,	  as	  was	  the	  objective	  of	  the	  chosen	  five	  day	  time	  point.	  It	  was	  also	  confirmed	  that	  253	  
by	  10	  days,	  both	  intracellular	  and	  extracellular	  glucose	  levels	  had	  dropped	  dramatically,	  254	  
in	   some	   replicates	   to	   below	   detection	   limits.	   At	   10	   dpi	   therefore,	   there	   was	   no	  255	  
significant	  difference	  between	  the	  amount	  of	  glucose	  within	  the	  mutants	  and	  wild-­‐type.	  	  256	  
	  257	  
Dissecting	  the	  cold-­‐induced	  sporulation	  phenomenon	  258	  
The	  metabolomic	  data	  presented	  thus	  far	  has	  identified	  changes	  that	  have	  occurred	  to	  259	  
the	  metabolome	   of	   S.	  nodorum	  as	   a	   result	   of	   the	   deactivation	   of	  Gna1,	  Gba1	   or	  Gga1.	  260	  
Under	   these	   conditions,	   wild-­‐type	   SN15	   sporulates	   readily,	   whilst	   the	  mutant	   strains	  261	  
gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25	   do	   not	   sporulate	   for	   at	   least	   6	   weeks.	   The	   recorded	  262	  
metabolite	   abundances	   therefore	   likely	   reflect	   both	   direct	   and	   indirect	   metabolic	  263	  
consequences	  of	  the	  mutation.	  In	  a	  previous	  study	  by	  this	  laboratory,	  we	  demonstrated	  264	  
that	  ongoing	  cold	  stress	  was	  sufficient	  to	  induce	  moderate	  levels	  of	  asexual	  sporulation	  265	  
in	   the	   mutant	   strains	   (Gummer	   et	   al.,	   2012).	   As	   previous	   sporulation	   studies	   in	   S.	  266	  
nodorum	  have	  highlighted	  the	  role	  of	  primary	  metabolism	  in	  this	  developmental	  stage	  267	  
(IpCho	  et	  al.,	  2010;	  Lowe	  et	  al.,	  2009;	  Solomon	  et	  al.,	  2005;	  Solomon	  et	  al.,	  2006c;	  Tan	  et	  268	  
al.,	   2008),	   metabolomics	   was	   again	   used	   to	   dissect	   the	   cold-­‐induced	   response,	   and	  269	  
identify	  which	  metabolites	  are	  specifically	  associated	  with	  asexual	  sporulation.	  270	  
Each	   strain	   was	   incubated	   for	   6	   weeks	   before	   harvesting	   the	  mycelia	   for	   metabolite	  271	  
analysis	   (defined	   as	   ‘sporulating4°C’).	   These	   data	   were	   compared	   with	   the	   non-­‐272	  
sporulating	   metabolomes	   already	   measured	   (defined	   as	   ‘non-­‐sporulating22°C’).	   To	  273	  
highlight	   some	   of	   the	   metabolites	   associated	   with	   the	   cold-­‐stress	   response	   and	   to	  274	  
strengthen	   the	   argument	   of	   sporulation-­‐linked	   metabolites,	   cultures	   were	   also	  275	  
harvested	  at	  another	  time,	  after	  just	  3	  weeks	  at	  4°C	  (defined	  as	  ‘near-­‐sporulating4°C’).	  	  276	  
Examination	  of	  the	  strains	  at	  the	  near-­‐sporulating4°C	  stage	  confirmed	  the	  mutant	  strains	  277	  
of	   S.	   nodorum,	   gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25	   showed	   no	   visible	   signs	   of	   pycnidia	  278	  
formation,	   and	  were	  non-­‐sporulating,	   as	   observed	  with	   the	   cultures	  harvested	  10	  dpi	  279	  
(ie.	   non-­‐sporulating22°C).	   At	   sporulation4°C,	   each	   of	   the	   mutant	   strains	   differentiated	  280	  
mature	  pycnidia	  and	  viable	  asexual	  spores	  could	  be	  harvested	  as	  previously	  described	  281	  
(Gummer	  et	  al.,	  2012).	  Metabolites	  were	  harvested	  from	  all	  cultures,	  analysed	  by	  GC-­‐MS	  282	  
and	  the	  normalised	  metabolite	  abundances	  for	  each	  of	  the	  strains	  under	  all	  conditions	  283	  
were	  modelled	  by	  PCA	  (Fig.	  3).	  284	  
The	  PCA	  Scores	  plot	   identified	  differences	   in	   the	  wild-­‐type	  strain	  SN15,	  under	  each	  of	  285	  
the	   culture	   conditions.	   This	   was	   observed	   in	   the	   projections	   of	   both	   principal	  286	  
components	  one	  (PC1:	  30%)	  and	  two	  (PC2:	  16%).	  Both	  components	  also	  displayed	  the	  287	  
collective	   similarities	   of	   the	   chilled	   non-­‐sporulating	   mutant	   strains,	   with	   the	   non-­‐288	  
sporulating	   mutants	   cultured	   at	   22°C.	   The	   latter	   non-­‐sporulating	   strains	   however	  289	  
clustered	   with	   the	   sporulating	   mutants,	   and	   interestingly	   also	   with	   SN15	   under	   the	  290	  
comparative	   sporulating	   culture	   conditions.	  An	  analysis	  of	   the	  PCA	  Loadings	   revealed	  291	  
that	  the	  scores	  were	  highly	   influenced	  by	  only	  a	   few	  metabolites.	  The	  most	   influential	  292	  
metabolites	  of	  PCs1	  and	  2	  are	  displayed	  in	  Fig.	  4.	  	  293	  
Statistical	  differences	  in	  metabolite	  abundances	  between	  each	  of	  the	  S.	  nodorum	  mutant	  294	  
strains	   gna1-­‐35,	   gba1-­‐6	   and	   gga1-­‐25	   compared	   to	   the	   wild-­‐type	   SN15,	   at	   near-­‐295	  
sporulating4°C	  and	  sporulating4°C	  conditions	  are	  shown	  in	  Supplementary	  Tables	  3	  and	  296	  
4.	   However	   it	   was	   the	   metabolites	   that	   were	   changing	   within	   the	   individual	   mutant	  297	  
strains	   during	   the	   transition	   to	   sporulation	   which	   was	   of	   most	   interest.	   These	  298	  
abundance	   changes	   are	   summarised	   in	   Tables	   3	   and	   4.	   Generally,	   the	   abundance	  299	  
changes	   of	   most	   of	   the	  metabolites	   were	   comparable	   between	  mutants.	   Some	   of	   the	  300	  
more	   notable	  metabolite	   changes	   identified	   during	   cold-­‐induced	   sporulation	   included	  301	  
the	   increase	   in	   abundance	  of	  putrescine,	   trehalose	   and	  octadecanoic	   acid	   in	   all	   of	   the	  302	  
mutants	   from	   both	   non-­‐sporulating22°C	   or	   near-­‐sporulating4°C	   conditions	   to	  303	  
sporulating4°C.	   Surprisingly,	   mannitol	   levels	   decreased	   in	   each	   of	   the	   mutants	   during	  304	  
cold-­‐induced	   differentiation	   as	   did	   the	   previously	   described	   metabolite	  305	  
Unknown_35.27_2194_319	  (IpCho	  et	  al.,	  2010).	  The	  putative	  roles	  of	  these	  metabolites	  306	  
are	  discussed	  in	  further	  detail	  below.	  	  307	  
308	  
DISCUSSION	  309	  
Glucose	  metabolism	  is	  altered	  in	  the	  gna1,	  gba1	  and	  gga1	  strains	  310	  
After	   five	   days	   of	   growth,	   S.	   nodorum	   SN15	   had	   a	   significantly	   higher	   amount	   of	  311	  
intracellular	   glucose	   than	   the	   mutant	   strains.	   The	   average	   abundance	   of	   glucose	  312	  
detected	  for	  SN15	  was	  4.6,	  5.0	  and	  3.7	  times	  more	  than	  observed	  for	  the	  gna1-­‐35,	  gba1-­‐313	  
6	   and	  gga1-­‐25	   strains	   respectively.	  However,	   at	   this	   time	  point	  glucose	  still	   remained	  314	  
available	   in	   high	   abundance	   in	   the	   growth	   medium	   in	   both	   wild-­‐type	   and	   mutant	  315	  
strains.	   By	   10	   days	   intracellular	   glucose	   levels	   had	   dropped	   dramatically,	   in	   some	  316	  
replicates	   to	   below	   detection	   limits,	   such	   that	   there	   was	   no	   significant	   difference	  317	  
between	  the	  amount	  of	  glucose	  within	  the	  mutants	  and	  wild-­‐type.	  The	  large	  abundance	  318	  
of	   intracellular	  glucose	  observed	   in	  SN15	   five	  dpi	  was	  not	   seen	   in	  any	  of	   the	  mutants	  319	  
under	   the	   conditions	   tested.	  As	   yet,	   extracellular	   glucose	  was	   still	   available	   at	   similar	  320	  
amounts	  in	  all	  strains,	  we	  conclude	  that	  the	  mutant	  strains	  may	  be	  further	  metabolizing	  321	  
the	  intracellular	  glucose	  rather	  than	  accumulating	  it	  like	  the	  wild-­‐type.	  	  322	  
The	   role	   of	   GPCRs	   and	   their	   associated	   G-­‐proteins	   in	   nutrient	   sensing	   has	   been	  323	  
demonstrated	   in	   a	   number	   of	   fungal	   systems.	   Glucose	   sensing	   in	   S.	   cerevisiae	   for	  324	  
example	  has	  been	  shown	  to	  occur	  through	  the	  GPCR	  Gpr1.	  Glucose	  triggers	  an	  increase	  325	  
in	   cellular	   cAMP	   that	   is	   dependent	   on	   the	   Gα	   subunit	   (Gpa2)	   of	   the	   coupled	  326	  
heterotrimeric	  G-­‐protein,	  which	  begins	   a	  protein	  kinase	  A	   (PKA)-­‐mediated	   cascade	  of	  327	  
protein	  phosphorylation	  (Kraakman	  et	  al.,	  1999).	  Here,	  the	  inactivation	  of	  Gna1,	  Gba1	  or	  328	  
Gga1	   alters	  glucose	  metabolism,	  possibly	  a	   result	  of	  a	  defect	   in	  detecting	   the	  nutrient	  329	  
levels	  available	  to	  the	  fungus,	  where	  the	  fate	  of	  glucose	  within	  the	  cell	  is	  changed.	  	  330	  
Li	  et	  al.	  (2006)	  have	  also	  investigated	  the	  role	  of	  G-­‐protein	  signalling	  on	  carbon	  source-­‐331	  
dependent	   growth	   in	  Neurospora	  crassa.	   They	   demonstrated	   a	   critical	   role	   for	   GNA-­‐1	  332	  
(Class	   I	  Gα	   subunit)	   signalling	   in	   responding	   to	  different	   carbon	   sources	  by	  assessing	  333	  
the	  growth	  of	  an	  N.	  crassa	  mutants	  lacking	  either	  the	  G-­‐protein	  coupled	  receptor	  GPR-­‐4	  334	  
or	   GNA-­‐1.	   Interestingly,	   growth	   on	   glucose	   was	   relatively	   unaffected	   compared	   to	  335	  
growth	   on	   either	   glycerol	   or	   mannitol	   but	   this	   phenotype	   could	   be	   partially	  336	  
complemented	  by	  the	  exogenous	  application	  of	  cAMP.	  337	  
	  338	  
There	  are	  multiple	  metabolic	  perturbations	  in	  the	  gna1,	  gba1	  and	  339	  
ggaA	  strains	  340	  
The	  analysis	  of	   the	  primary	  metabolite	  abundances	  at	   five	  and	  10	  dpi	  highlighted	   the	  341	  
significant	   effect	   on	   metabolism	   caused	   by	   the	   inactivation	   of	   Gna1,	   Gba1	   and	   Gga1.	  342	  
Consistent	  with	  the	  deletion	  of	  the	  individual	  G-­‐protein	  subunits	  of	  A.	  nidulans	  (Lafon	  et	  343	  
al.,	   2005)	   and	   other	   fungal	   systems	   (Kraakman	   et	   al.,	   1999)	   is	   an	   effect	   on	   the	  344	  
disaccharide	   trehalose.	   The	   decline	   in	   intracellular	   and	   extracellular	   glucose	   10	   dpi	  345	  
coincides	  with	  a	  dramatic	  increase	  in	  trehalose	  within	  the	  S.	  nodorum	  wild-­‐type	  strain.	  346	  
Within	  the	  mutant	  strains,	  no	  significant	  change	  in	  trehalose	  abundance	  occurs	  between	  347	  
five	   and	   10	   dpi.	   insight into sexual development	   The	   accumulation	   of	   this	   metabolite	   has	  348	  
previously	  been	  correlated	  with	  asexual	  sporulation	  in	  S.	  nodorum	  both	   in	  vitro	  and	   in	  349	  
planta	  (Lowe	  et	  al.,	  2009).	  Therefore,	  constitutive	  catabolism	  of	  trehalose	  in	  S.	  nodorum	  350	  
is	   consistent	  with	   the	   inability	   of	   the	  mutant	   strains	  gna1-­‐35,	  gba1-­‐6	   and	  gga1-­‐25	   to	  351	  
sporulate	  under	  these	  experimental	  conditions,	  as	  trehalose	  is	  important	  for	  the	  growth	  352	  
and	  development	  of	  eukaryotic	  cells	  (Lowe	  et	  al.,	  2009;	  Wilson	  et	  al.,	  2007).	  	  353	  
Constitutive	  catabolism	  of	  trehalose	  in	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25	  might	  also	  explain	  354	  
the	   reduced	   accumulation	   of	   glucose.	   In	   SN15	   the	   depletion	   of	   intracellular	   glucose	  355	  
coincides	  with	  an	  accumulation	  of	  trehalose.	  It	  therefore	  appears	  that	  trehalose	  acts	  as	  a	  356	  
sink	   for	   excess	   glucose.	   Lafon	   et	  al.,	   (2005)	   also	   observed	   the	   (albeit	   less	   significant,	  357	  
but)	   reduced	  catabolism	  of	   trehalose	   in	   the	   sfaD	  and	  gpgA	  strains	  of	  A.	  nidulans.	   This	  358	  
implies	  a	  role	  for	  all	  three	  G-­‐protein	  subunits	  in	  trehalose	  degradation,	  and	  supports	  a	  359	  
similar	  requirement	  for	  Gna1,	  Gba1	  and	  Gga1	  in	  S.	  nodorum.	  	  360	  
In	  wild-­‐type,	  the	  drop	  in	  glucose	  abundance	  at	  10	  days	  of	  growth	  also	  coincides	  with	  a	  361	  
reduction	  in	  intracellular	  mannitol.	  The	  same	  trend	  was	  observed	  in	  gba1-­‐6,	  but	  not	  for	  362	  
gna1-­‐35	  or	  gga1-­‐25.	   The	   latter	   two	   did	   not	   change	   significantly	   between	   five	   and	   10	  363	  
days,	   with	   mannitol	   remaining	   at	   a	   higher	   abundance.	   The	   abundance	   of	   mannitol	  364	  
observed	   in	   the	  combined	   intra/extracellular	  metabolite	  extracts	  between	   five	  and	  10	  365	  
days	  however	  does	  not	  change	  significantly	  in	  wild-­‐type.	  But	  with	  intracellular	  mannitol	  366	  
showing	   a	   reduction,	   it	   is	   suggested	   that	   mannitol	   was	   being	   secreted	   by	   SN15	   and	  367	  
gba1-­‐6.	   Likewise,	   the	   intracellular	   mannitol	   pool	   of	   gga1-­‐25	   changed	   insignificantly	  368	  
over	  the	  growth	  period,	  yet	  when	  comparing	  the	  intra/extracellular	  amount,	  there	  was	  369	  
a	   significant	   (p	   >	   0.05)	   increase	   in	  mannitol.	   This	   strain	   is	   therefore	   likely	   secreting	  370	  
excess	  mannitol	  into	  the	  growth	  medium.	  	  371	  
Mannitol	   secretion	   has	   been	   reported	   in	   other	   phytophathogenic	   species	   including	  372	  
Alternaria	   alternata,	   and	   is	   believed	   to	   play	   a	   role	   in	   quenching	   the	   reactive	   oxygen	  373	  
species	  of	  the	  plant	  defence	  response	  (Jennings	  et	  al.,	  1998;	  Jennings	  et	  al.,	  2002).	  This	  374	  
is	  the	  first	  reported	  evidence	  of	  mannitol	  secretion	  by	  S.	  nodorum.	  375	  
Changes	  to	  mannitol	  metabolism	  in	  the	  gna1	  strain	  are	  also	  consistent	  with	  reports	  by	  376	  
(Casey	  et	  al.,	   2010)	  which	   found	  mannitol	   dehydrogenase	   (Mdh1)	   to	   be	   the	  most	   up-­‐377	  
regulated	  protein	  in	  the	  S.	  nodorum	  mutant	  gna1-­‐35	  strain	  when	  compared	  to	  the	  wild-­‐378	  
type	   SN15,	   whilst	   mannitol	   1-­‐phosphate	   dehydrogenase	   (Mpd1)	   was	   significantly	  379	  
down-­‐regulated.	  This	  metabolomic	  analysis	  further	  supports	  a	  role	  for	  Gna1,	  as	  well	  as	  380	  
Gba1	   and	   Gga1,	   in	   regulating	   mannitol	   metabolism	   in	   S.	   nodorum,	   although	   its	   exact	  381	  
function	  is	  as	  yet	  unclear.	  382	  
The	   disaccharide	   lactose	   was	   more	   abundant	   in	   the	   S.	   nodorum	   mutant	   strains	  383	  
compared	   to	   the	   wild-­‐type.	   The	   metabolism	   of	   lactose	   is	   of	   emerging	   interest	   in	   S.	  384	  
nodorum.	   In	   the	   ascomycete	   Hypocrea	   jecorina,	   as	   with	   some	   other	   dissacharides,	  385	  
lactose	   can	   induce	   cellulase	   formation.	   Lactose	   has	   also	   shown	   this	   induction	   in	  386	  
Acremonium	  cellulolyticus	   (Fang	  et	  al.,	  2008)	  and	   in	  Trichoderma	  reesei,	  where	   lactose	  387	  
has	  been	  demonstrated	   to	   increase	   the	  expression	  of	  a	  number	  of	  cellulose-­‐degrading	  388	  
enzymes	   (Foreman	   et	   al.,	   2003).	   A.	   niger	   on	   the	   other	   hand	   is	   unable	   to	   metabolise	  389	  
lactose	  (Seiboth	  et	  al.,	  2007).	  The	  S.	  nodorum	  genome	  encodes	   the	  necessary	  enzymes	  390	  
for	  lactose	  degradation,	  although	  the	  biochemical	  pathway	  consists	  of	  a	  number	  of	  low	  391	  
specificity	  enzymes.	  Importantly	  however,	  as	  previously	  demonstrated,	  S.	  nodorum	  can	  392	  
utilise	  lactose	  as	  a	  sole	  carbon	  source	  (Gummer	  et	  al.,	  2012).	  The	  slower	  growth	  of	  the	  393	  
gga1-­‐25	  strain	  on	  lactose	  combined	  with	  the	  increased	  accumulation	  of	  this	  metabolite	  394	  
when	   grown	   on	   glucose,	   suggests	   that	   lactose	   is	   geared	   towards	   anabolism	   in	   S.	  395	  
nodorum	  gga1-­‐25,	  as	  may	  be	  the	  case	  with	  a	  number	  of	  the	  gga1	  metabolites.	  	  396	  
	  397	  
Dissecting	  the	  cold-­‐induced	  sporulation	  phenomenom	  398	  
We	   have	   recently	   showed	   that	   the	   prolonged	   incubation	   of	   the	   G-­‐protein	   signalling	  399	  
mutants	   at	   4°C	   complemented	   the	   sporulation	   defect.	   This	   observation	   provides	   a	  400	  
unique	  opportunity	   to	   study	   the	  metabolome	  of	  S.	  nodorum	   as	   it	  differentiates	   from	  a	  401	  
mature	  non-­‐sporulating	  culture	  to	  an	  asexually	  sporulating	  culture.	  402	  
A	  number	  of	  metabolites	  followed	  a	  pattern	  of	  increasing	  abundance	  in	  the	  metabolome	  403	  
after	   three	  weeks	   (in	   the	   near-­‐sporulating4°C	   conditions),	   but	  within	   six	  weeks	   under	  404	  
these	   conditions	   (sporulating4°C),	   the	   same	   metabolites	   depleted	   to	   within	   a	   similar	  405	  
range	   as	   those	   10	   dpi	   (non-­‐sporulating22°C).	   These	   metabolites	   are	   believed	   to	   have	  406	  
been	   induced	  by	   the	   cold-­‐stress,	   rather	   than	   linked	   specifically	   to	   sporulation	   events,	  407	  
and	   likely	   depleted	   upon	   starvation,	   following	   depletion	   of	   the	   carbon	   source	   by	   six	  408	  
weeks	   at	   the	   cooler	   temperature.	   The	   change	   in	   these	   metabolites	   also	   followed	   a	  409	  
similar	  pattern	  of	  abundance	  in	  the	  wild-­‐type	  strain	  SN15.	  410	  
The	  sugar-­‐alcohol	  arabitol	  increased	  in	  abundance	  when	  the	  cultures	  were	  subjected	  to	  411	  
three	  weeks	  growth	  at	  4°C.	  The	  maximum	  abundance	   for	   this	  metabolite	  across	  all	  of	  412	  
the	  culture	  conditions	  was	  also	  recorded	  under	  the	  near-­‐sporulating4°C	  conditions,	  and	  413	  
again	  in	  the	  gga1-­‐25	  strain.	  As	  one	  of	  the	  four	  most	  abundant	  metabolites	  in	  S.	  nodorum,	  414	  
arabitol	   was	   previously	   investigated	   and	   determined	   to	   play	   an	   osmoprotective	   role	  415	  
within	  S.	  nodorum	  (Lowe	  et	  al.,	  2008).	  This	  study	  now	  suggests	  that	  this	  polyol	  may	  also	  416	  
play	  a	  role	  in	  the	  cold-­‐stress	  tolerance	  of	  S.	  nodorum.	  417	  
Another	  interesting	  molecule	  observed	  during	  the	  course	  of	  this	  study	  was	  alternariol.	  418	  
Alternariol	  is	  a	  mycotoxin	  and	  of	  considerable	  interest	  due	  to	  the	  implications	  it	  poses	  419	  
to	   human	   health,	   by	   exposure	   through	   crop	   contamination	   (Tan	   et	   al.,	   2009b).	   It	   is	  420	  
therefore	   of	   significant	   interest	   that	   the	   increased	   abundance	   of	   this	   secondary	  421	  
metabolite	  is	  also	  found	  in	  the	  near-­‐sporulating4°C,	  cold-­‐stressed	  strains.	  The	  maximum	  422	  
abundance	   was	   detected	   in	   the	   wild-­‐type	   strain	   SN15.	   The	   dramatic	   depletion	   of	  423	  
intracellular	  alternariol	  from	  near-­‐sporulating4°C,	  to	  the	  sporulating4°C	  cultures	  of	  SN15,	  424	  
where	   it	  was	  undetected,	   is	  also	  of	   interest.	  Previous	  studies	  on	  sporulation-­‐impaired	  425	  
mutants	  of	  S.	  nodorum	   have	  previously	   linked	  alternariol	   and	   sporulation	  and	   further	  426	  
studies	  are	  now	  required	  to	  understand	  the	  role	  of	  this	  mycotoxin	  during	  differentiation	  427	  
(IpCho	  et	  al.,	  2010).	  428	  
The	  comparison	  of	  the	  non-­‐sporulating	  metabolomes	  of	  the	  S.	  nodorum	  gna1-­‐35,	  gba1-­‐6	  429	  
and	  gga1-­‐25	   strains	  with	   those	  extracted	   from	   the	   sporulation4°C	   cultures	   identified	  a	  430	  
number	   of	   metabolites	   correlating	   with	   the	   onset	   of	   sporulation.	   Some	   of	   the	  431	  
metabolites,	   although	   following	   a	   similar	   depletion	   in	   the	   transition	   from	   the	   non-­‐432	  
sporulating22°C	   to	   the	   sporulating4°C,	   were	   considered	   to	   have	   changed	   as	   a	   result	   of	  433	  
their	  relationship	  to	  glucose	  abundance.	  Fumarate,	  malate,	  fructose	  and	  mannitol	  were	  434	  
among	  these,	  and	  not	  believed	  direct	  ‘markers’	  of	  either	  phenotype.	  435	  
Putrescine	   was	   detected	   in	   all	   cold-­‐induced	   sporulating	   mutant	   strains.	   Because	   this	  436	  
metabolite	   is	   also	   present	   in	   the	   comparable	   cultures	   of	   SN15,	   it	   is	   unlikely	   to	   be	  437	  
specifically	   associated	  with	   sporulation.	   Putrescine	   in	  S.	  nodorum	   is	   derived	   from	   the	  438	  
biochemical	   synthesis	   and	   degradation	   of	   arginine,	   all	   of	   the	   enzymes	   for	   which	   S.	  439	  
nodorum	   possesses.	   The	  disruption	   of	   some	  of	   the	   key	   enzymes	   of	   this	   pathway	   in	  S.	  440	  
nodorum	   may	   provide	   further	   insight	   into	   asexual	   development.	   Ornithine	  441	  
decarboxylase	   has	   been	   previously	   disrupted	   in	   S.	   nodorum.	   Whilst	   a	   reduction	   in	  442	  
pathogenicity	  was	  identified	  in	  the	  mutants,	  it	  was	  unclear	  whether	  or	  not	  the	  mutation	  443	  
affected	  sporulation	  (Bailey	  et	  al.,	  2000).	  	  444	  
The	   biochemical	   pathways	   of	   amine	   and	   polyamine	   degradation	   are	   used	   to	   derive	  445	  
nutrition	   from	   existing	   metabolites	   (Caspi	   et	   al.,	   2008).	   The	   biochemical	   process	   of	  446	  
allantoin	  degradation	  forms	  one	  of	  these	  pathways	  and	  genomic	  evidence	  suggests	  that	  447	  
allantoin	  can	  be	  degraded	  to	  ureidoglycolate	  (urea	  producing)	  in	  S.	  nodorum.	  Allantoin	  448	  
was	   significantly	   more	   abundant	   in	   the	   mutant	   strains	   five	   dpi,	   and	   by	   10	   dpi	   had	  449	  
accumulated	  to	  8.6,	  10.1,	  and	  5.0	  times	  higher	  abundance	  in	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐450	  
25,	   compared	   to	  wild-­‐type,	   respectively.	  The	  data	  suggests	  either	  an	   increased	  rate	  of	  451	  
urate	   degradation	   to	   allantoin	   in	   the	   mutant	   strains,	   or	   the	   reduced	  452	  
consumption/degradation	   of	   allantoin.	   Both	   options	   indicate	   likely	   differences	   in	   the	  453	  
nitrogen	   requirements	   of	   the	   mutant	   strains	   compared	   to	   the	   wild-­‐type.	   In	   near-­‐454	  
sporulating4°C	   cultures,	   the	  abundance	  of	  allantoin	  was	  reduced	   in	   the	  mutant	   strains,	  455	  
such	   that	   it	   was	   no	   longer	   significantly	   different	   to	   wild-­‐type.	   In	   all	   strains,	   in	   the	  456	  
transition	   from	   the	   chilled	   near-­‐sporulating4°C	   phenotype,	   to	   the	   sporulating4°C,	  457	  
allantoin	  again	  increased	  in	  abundance.	  	  458	  
The	  abundance	  of	  trehalose	  in	  these	  strains	  did	  not	  change	  significantly	  in	  the	  transition	  459	  
of	   the	  non-­‐sporulating22°C	  phenotype	  to	  the	  near-­‐sporulating4°C.	  The	  abundance	  of	   this	  460	  
metabolite	   was	   therefore	   not	   correlated	   with	   the	   cold	   temperature.	   Just	   prior	   to	  461	  
sporulation	   (near-­‐sporulating4°C)	   the	   gna1,	   gba1	   and	   ggaA	   strains	   were	   significantly	  462	  
lower	   in	   trehalose	   abundance	   than	   the	   sporulating	   (sporulating4°C)	   cultures.	   In	   the	  463	  
differentiation	   of	   this	   non-­‐sporulating	   phenotype	   to	   that	   of	   a	   sporulating	   phenotype,	  464	  
trehalose	   increased	  1.8,	  4.0	  and	  3.7	   fold	   in	  gna1-­‐35,	  gba1-­‐6	   and	  gga1-­‐25	   respectively.	  465	  
Considering	  the	  huge	  natural	  abundance	  of	  trehalose	  in	  S.	  nodorum,	  these	  fold	  changes	  466	  
in	  abundance	  are	  noteworthy.	  The	  result	  conclusively	  supports	  the	  results	  of	  Lowe	  et	  al.	  467	  
(2009)	   in	   finding	   that	   the	   accumulation	   of	   trehalose	   is	   correlated	   with	   asexual	  468	  
sporulation	  in	  S.	  nodorum.	  469	  
Of	   further	   interest	   in	   this	   dataset	   are	   the	   unidentified	   metabolites	  470	  
unknown_35.27_2194_319,	  and	  unknown_52.11_3560_307.	  	  Unknown_35.27_2194_319	  471	  
is	   a	  metabolite	   that	  was	   found	   common	   to	  metabolite	   extracts	   of	   the	  non-­‐sporulating	  472	  
mutant	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25,	  but	  not	  the	  wild-­‐type	  SN15	  and	  therefore	  473	  
will	   likely	   play	   a	   role	   in	   asexual	   sporulation,	   perhaps	   as	   an	   inhibitor,	   or	   providing	   a	  474	  
necessary	   precursor	   for	   sporulation	   events.	   It	   is	   also	   interesting	   to	   note	   that	  475	  
Unknown_35.27_2194_319	  was	  previously	  detected	   in	  S.	  nodorum	   SN15	   following	   the	  476	  
first	   days	  of	   pycnidia	  development	   (5	  dpi),	   however	  by	  10	  dpi	  when	   sporulation	  was	  477	  
rampant	   in	   SN15,	   the	  metabolite	  was	   completely	   absent	   from	   the	   SN15	  metabolome,	  478	  
whilst	   remaining	   in	   the	   non-­‐sporulating	   mutants	   under	   the	   equivalent	   growth	  479	  
conditions.	  480	  
Conversely	   to	   Unknown_35.27_2194_319,	   Unknown_52.11_3560_307	   is	   a	   metabolite	  481	  
common	  to	  metabolite	  extracts	  of	  S.	  nodorum	  SN15,	  but	  not	  of	  the	  mutant	  strains	  during	  482	  
sporulation.	   Although	   it	   was	   previously	   detected	   in	   gna1-­‐35	   and	   gga1-­‐25	   when	   not	  483	  
undergoing	   sporulation,	   this	   metabolite	   was	   significantly	   depleted	   compared	   to	   the	  484	  
asexually	  sporulating	  wild-­‐type	  SN15	  under	  the	  same	  growth	  conditions.	  This	  provides	  485	  
evidence	   that	   this	   metabolite	   is	   likely	   a	   biological	   ‘marker’	   for	   the	   onset	   of	   asexual	  486	  
sporulation	  in	  S.	  nodorum.	  Further	  experimentation	  is	  required	  to	  elucidate	  the	  identity	  487	  
of	   these	   metabolites,	   which	   will	   inevitably	   help	   further	   dissect	   the	   lifecycle	   of	   S.	  488	  
nodorum	  and	  in	  particular,	  asexual	  sporulation.	  489	  
	  490	  
Comparative	  analysis	  of	  the	  metabolome	  and	  proteome	  of	  the	  S.	  491	  
nodorum	  gna1-­‐35	  strain	  492	  
It	   is	   interesting	   to	   note	   the	   biochemical	   ‘intersection’	   of	   glucose	   6-­‐phosphate	   in	   S.	  493	  
nodorum.	   Casey	  et	  al.	   (2010)	   observed	  differentially	   up	   and	  down-­‐regulated	   enzymes	  494	  
involving	  glucose	  6-­‐phosphate,	  between	  the	  S.	  nodorum	  gna1-­‐35	  mutant	  and	  the	  wild-­‐495	  
type	  SN15,	   including	  glucose	  6-­‐phosphate	  1-­‐dehydrogenase,	  phosphoglucomutase	  and	  496	  
inositol	  3-­‐phosphate	  synthase.	  Glucose	  6-­‐phosphate	  1-­‐dehydrogenase	  provides	  glucose	  497	  
6-­‐phosphate	   to	   the	   pentose	   phosphate	   pathway	   (PPP)	   and	   together	   with	   the	  498	  
observation	  of	  the	  up-­‐regulation	  of	  a	  number	  of	  enzymes	  of	  the	  PPP	  in	  gna1-­‐35,	  it	  was	  499	  
concluded	  that	  Gna1	  signalling	  has	  an	  important	  regulatory	  role	  in	  determining	  the	  fate	  500	  
of	  glucose	  6-­‐phosphate	  within	  S.	  nodorum	  (Casey	  et	  al.,	  2010).	  501	  
Further	  to	  this,	   the	  up-­‐regulation	  of	   the	  PPP	   in	  gna1-­‐35	   could	  be	  consequential	  or	   the	  502	  
reason	   for	   the	   mutant	   strains’	   reduced	   growth	   rates	   and	   inability	   to	   form	   pycnidia	  503	  
under	   these	   experimental	   conditions.	  With	   one	   of	   the	   primary	   objectives	   of	   the	   PPP	  504	  
being	  to	  supply	  growing	  cells	  with	  pentose	  for	  the	  synthesis	  of	  nucleotides,	  from	  ribose	  505	  
5-­‐phosphate,	  this	  thesis	  further	  supports	  the	  conclusion	  by	  Casey	  et	  al.	  2010.	  	  506	  
In	   the	  gna1,	  gba1	   and	  ggaA	   strains	   at	   5	   dpi,	   there	   is	   evidence	   to	   suggest	   rather	   than	  507	  
converting	  glucose	  6-­‐phosphate	   to	   fructose	  6-­‐phosphate	   (EC	  2.7.1.1;	  ATP	  +	  D-­‐Glucose	  508	  
<=>	   ADP	   +	   D-­‐Glucose	   6-­‐phosphate)	   and	   committing	   it	   to	   glycolysis	   by	   further	  509	  
phosphorylation	   to	   fructose	   1,6-­‐bisphosphate	   (EC	   2.7.1.11;	   ATP	   +	   D-­‐fructose	   6-­‐510	  
phosphate	  =	  ADP	  +	  D-­‐fructose	  1,6-­‐bisphosphate),	  there	  is	  a	  preference	  for	  conversion	  of	  511	  
glucose	   6-­‐phosphate	   to	   other	   sugar	   phosphates.	   The	   regulation	   would	   likely	   be	  512	  
occurring	  through	  the	  allosteric	   inhibition	  of	  phosphofructokinase	  (PFK:	  EC;	  2.7.1.11).	  513	  
The	   inhibition	   maybe	   caused	   by	   the	   higher	   abundance	   of	   citrate	   in	   these	   strains	  514	  
comparative	  to	  SN15,	  resulting	  in	  an	  increased	  abundance	  of	  myo-­‐inositol	  at	  this	  earlier	  515	  
time.	   This	   accumulation	   is	   supported	   by	   the	   observed	   up-­‐regulation	   of	   inositol	   3-­‐516	  
phosphate	  synthase	  in	  gna1,	  comparative	  to	  SN15	  (Casey	  et	  al.,	  2010).	  517	  
With	  the	  aforementioned	  changes	  to	  glucose	  metabolism	  in	  the	  mutant	  strains,	  and	  as	  518	  
glucose	   6-­‐phosphate	   provides	   a	   precursor	   requiring	   only	   two	   to	   three	   enzymatic	  519	  
reactions	  to	  form	  mannitol,	  trehalose	  or	  myo-­‐inositol	  (Figure	  5),	  the	  metabolomic	  data	  520	  
also	  supports	  a	  regulatory	  role	  for	  Gna1	  in	  the	  fate	  of	  glucose	  6-­‐phosphate.	  521	  
522	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FIGURE	  LEGENDS	  655	  
Fig.	  1.	  Normalized	  mean	  abundances	  (±	  STD)*	  of	  mannitol	  in	  S.	  nodorum	  wild-­‐type	  656	  
strain	  SN15	  (Sn)	  and	  mutant	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25	  at	  5	  and	  10	  dpi.	  657	  
*Separation	  of	  the	  circles	  represents	  statistically	  different	  (p	  <	  0.05)	  group	  means	  as	  658	  
determined	  by	  Tukey-­‐Kramer	  analysis.	  	  659	  
	  660	  
Fig.	  2.	  Normalized	  mean	  abundances*	  (±	  std)	  of	  glucose	  in	  S.	  nodorum	  wild-­‐type	  strain	  661	  
SN15	  (Sn)	  and	  mutant	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25	  at	  5	  and	  10	  dpi.	  *Separation	  662	  
of	  the	  circles	  represents	  statistically	  different	  (p	  <	  0.05)	  group	  means	  as	  determined	  by	  663	  
Tukey-­‐Kramer	  analysis.	  664	  
	  665	  
Fig.	  3.	  PCA	  Scores	  plot	  displaying	  the	  Scores	  calculated	  from	  the	  normalised	  metabolite	  666	  
abundances	  of	  S.	  nodorum	  mutant	  strains	  grown	  under	  non-­‐sporulating	  and	  sporulating	  667	  
culture	  conditions.	  The	  mutant	  strains	  gna1-­‐35	  (α),	  gba1-­‐6	  (β)	  and	  gga1-­‐25	  (γ)	  were	  668	  
compared	  when	  sporulating	  (black	  circle),	  near	  sporulating	  (white	  circle)	  and	  non-­‐669	  
sporulating	  (open	  symbol).	  Wild-­‐type	  strain	  SN15	  (WT)	  sporulated	  under	  all	  670	  
conditions;	  the	  displayed	  symbols	  represent	  comparable	  culture	  conditions	  to	  those	  of	  671	  
the	  mutant	  strains.	  672	  
	  673	  
Fig.	  4.	  The	  calculated	  loadings	  values	  contributing	  to	  the	  projections	  of	  the	  S.	  nodorum	  674	  
metabolites	  from	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  gga1-­‐25	  of	  the	  PCA	  Scores	  in	  Fig.	  3.	  675	  
	  676	  
Fig.	  5.	  A	  schematic	  biochemical	  pathway	  outlining	  the	  fate	  of	  glucose	  6-­‐phosphate	  as	  677	  
determined	  by	  Casey	  et	  al.	  2010;	  with	  added	  detail	  of	  metabolite	  data	  from	  10	  dpi	  (this	  678	  
thesis).	  “+”	  and	  “-­‐“-­‐symbols	  indicate	  the	  relative	  enzyme	  and	  metabolite	  abundances	  of	  679	  
S.	  nodorum	  strain	  gna1-­‐35	  comparative	  to	  wild-­‐type	  SN15.	  1.	  Phosphoglucomutase;	  2.	  680	  
Glucose	  6-­‐phosphate	  1-­‐dehydrogenase;	  3.	  Inositol	  3-­‐phosphate	  synthase;	  4.	  Mannitol	  1-­‐681	  
phosphate	  dehydrogenase	  (Mpd1);	  5.	  Mannitol	  dehydrogenase	  (Mdh1);	  6.	  6-­‐682	  
Phosphogluconate	  dehydrogenase;	  7.	  Transketolase;	  8.	  Transaldolase;	  9.	  3-­‐Deoxy-­‐7-­‐683	  
phosphoheptulonate	  synthase.	  Adapted	  from	  Casey	  et	  al.	  2010.	  684	  
Table	   1.	   Normalised	   mean	   abundance	   (±	   STD)*	   of	   identified	   metabolites	   contributing	   to	   the	  
differences	  between	  the	  metabolome’s	  of	  S.	  nodorum	  SN15	  and	  mutant	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  
gga1-­‐25	  after	  5	  days	  of	  growth.	  	  
	  	  
	   SN15	   gna1-­‐35	   gba1-­‐6	   gga1-­‐25	  
Metabolite	  ID	   Mean	   ±	   STD	   Mean	   ±	   STD	   Mean	   ±	   STD	   Mean	   ±	   STD	  
Lactic	  acid	  2TMS_10.93_1060_147	   2.85	   ±	   0.5	   10	   ±	   2.52	   4.41	   ±	   2.52	   8	   ±	   2.07	  
L-­‐Isoleucine	  2TMS_17.29_1295_158	   0	   ±	   0	   0.27	   ±	   0.51	   0.83	   ±	   0.51	   0.92	   ±	   0.19	  
L-­‐Proline	  2TMS_17.41_1300_142	   0	   ±	   0	   2.86	   ±	   1.1	   3.35	   ±	   1.1	   3.22	   ±	   0.54	  
L-­‐Glycine	  3TMS_17.61_1308_174	   0.77	   ±	   0.13	   1.6	   ±	   0.55	   1.66	   ±	   0.55	   1.44	   ±	   0.28	  
Succinic	  acid	  2TMS_17.89_1319_147	   4.15	   ±	   0.88	   10	   ±	   6.09	   11.71	   ±	   6.09	   8.98	   ±	   2.58	  
L-­‐Threonine	  3TMS_19.60_1387_218	   1.57	   ±	   0.39	   2.25	   ±	   1.38	   3.49	   ±	   1.38	   2.46	   ±	   0.64	  
L-­‐Glutamic	  acid	  3TMS_24.85_1623_246	   3.42	   ±	   0.78	   6.45	   ±	   3.91	   9.89	   ±	   3.91	   8.32	   ±	   1.36	  
L-­‐Phenylalanine	  2TMS_24.99_1630_218	   0	   ±	   0	   0	   ±	   0.25	   0.59	   ±	   0.25	   0.26	   ±	   0.25	  
Arabinose	  4TMS_25.64_1663_103	   5.09	   ±	   1.23	   9.83	   ±	   2.9	   6.87	   ±	   2.9	   8.49	   ±	   1.77	  
L-­‐Asparagine	  3TMS_25.87_1674_116	   0.93	   ±	   1.2	   4.58	   ±	   2.7	   5.35	   ±	   2.7	   5.85	   ±	   1.65	  
D-­‐(-­‐)-­‐Ribose	  4TMS_25.97_1679_103	   0.03	   ±	   0.08	   0.3	   ±	   0.27	   0.38	   ±	   0.27	   0.3	   ±	   0.17	  
Arabitol	  5TMS_26.75_1719_217	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   4.27	   ±	   3.25	   1.95	   ±	   0.37	   0.25	   ±	   0.37	   4.74	   ±	   2.61	  
Ornithine	  4TMS_28.66_1815_142	  	  	  	  	  	  	  	  	  	  	  	   10	   ±	   4.2	   1.09	   ±	   0.38	   0.27	   ±	   0.38	   4.79	   ±	   0.63	  
Citric	  acid	  4TMS_28.70_1817_273	   1.98	   ±	   0.68	   4.76	   ±	   3.96	   6.23	   ±	   3.96	   10	   ±	   2.74	  
Allantoin	  4TMS_29.92_1878_331	   0.35	   ±	   0.19	   1.93	   ±	   0.91	   3.65	   ±	   0.91	   3.4	   ±	   0.3	  
Glucose	  5TMS_30.21_1884_319	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   10	   ±	   2.47	   2.01	   ±	   1.73	   1.61	   ±	   1.73	   2.47	   ±	   1.49	  
Glucose	  5TMS_30.39_1902_319	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   10	   ±	   2.43	   2.35	   ±	   1.02	   2.39	   ±	   1.02	   2.86	   ±	   0.61	  
L-­‐Lysine	  4TMS_30.58_1913_174	   2.29	   ±	   0.69	   2.69	   ±	   1.57	   2.39	   ±	   1.57	   4.1	   ±	   0.74	  
Mannitol	  6TMS_30.59_1914_319	   7.52	   ±	   0.86	   8.21	   ±	   0.94	   7.45	   ±	   0.94	   9.35	   ±	   1.19	  
L-­‐Tyrosine	  3TMS_30.91_1933_218	   0.42	   ±	   0.34	   1.33	   ±	   1.66	   3	   ±	   1.66	   2.28	   ±	   0.78	  
Glucopyranose	  5TMS_31.49_1967_204	  	   10	   ±	   4.57	   3.32	   ±	   1.67	   2.48	   ±	   1.67	   3.42	   ±	   3.98	  
myo-­‐inositol	  6TMS_32.32_2017_318	   0.82	   ±	   0.14	   2.1	   ±	   1.91	   3.49	   ±	   1.91	   4.28	   ±	   1.56	  
Octadecanoic	  acid	  1TMS_35.97_2243_117	   3.35	   ±	   1.11	   4.19	   ±	   4.15	   7.52	   ±	   4.15	   7.67	   ±	   0.9	  
Fructose	  5TMS_29.77_1870_103	  	  	  	  	  	  	  	  	  	  	  	  	  	   5.56	   ±	   3.34	   2.99	   ±	   2.07	   3.38	   ±	   2.07	   3.98	   ±	   0.83	  
Lactose	  8TMS_41.93_2670_204	   0.13	   ±	   0.16	   0.06	   ±	   0	   0	   ±	   0	   0.61	   ±	   0.21	  
Alternariol	  3TMS_45.58_2959_459	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   0.38	   ±	   0.26	   0.28	   ±	   0.25	   0.23	   ±	   0.25	   1.13	   ±	   0.66	  
Ergosterol_48.39_3199_363	   0.35	   ±	   0.34	   1.98	   ±	   0.68	   2.36	   ±	   0.68	   1.81	   ±	   0.32	  
	  
*	  The	  displayed	  metabolites	   each	   showed	   statistically	   significant	  differences	   in	   abundance	  between	  
SN15	  and	  at	   least	  one	  of	   the	  mutant	   strains;	   identified	   in	  bold.	  Metabolite	   abundances	  were	   scaled	  
according	   to	   the	   maximum	   recorded	   abundance	   for	   each	   metabolite,	   across	   all	   measured	   growth	  
conditions,	   which	  was	   scaled	   to	   10;	   underlined.	   Statistical	   significance	   (<0.05)	  was	   determined	   by	  
Tukey-­‐Kramer	  HSD.	  	  
	   	  
Table	   2.	   Normalised	   mean	   abundance	   (±	   STD)*	   of	   identified	   metabolites	   contributing	   to	   the	  
differences	  between	  the	  metabolome’s	  of	  S.	  nodorum	  SN15	  and	  mutant	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  
gga1-­‐25	  after	  10	  days	  of	  growth.	  	  
	  
	   SN15	   gna1-­‐35	   gba1-­‐6	   gga1-­‐25	  
Metabolite	  ID	   Mean	   	  	   STD	   Mean	   	  	   STD	   Mean	   	  	   STD	   Mean	   	  	   STD	  
L-­‐Valine	  2TMS_15.21_1211_144	   1.21	   ±	   0.19	   2.46	   ±	   0.49	   1.13	   ±	   0.98	   4.03	   ±	   0.66	  
L-­‐Serine	  2TMS_16.38_1258_132	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   4.62	   ±	   1.34	   6.45	   ±	   1.7	   4.14	   ±	   1.4	   8.95	   ±	   3.01	  
L-­‐Isoleucine	  2TMS_17.29_1295_158	  	  	  	  	  	  	  	  	  	  	  	  	  	   1.14	   ±	   0.23	   0.69	   ±	   0.55	   0.12	   ±	   0.3	   1.15	   ±	   0.62	  
L-­‐Proline	  2TMS_17.41_1300_142	   0.35	   ±	   0.54	   4.11	   ±	   0.98	   1.75	   ±	   1.15	   4.61	   ±	   3.14	  
L-­‐Glycine	  3TMS_17.61_1308_174	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1.06	   ±	   0.22	   2.23	   ±	   0.45	   0.82	   ±	   0.34	   1.79	   ±	   0.31	  
Succinic	  acid	  2TMS_17.89_1319_147	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   3.04	   ±	   0.91	   3.12	   ±	   0.73	   0.69	   ±	   1.07	   3.6	   ±	   0.37	  
Fumaric	  acid	  2TMS_18.89_1359_245	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2.91	   ±	   0.78	   8.5	   ±	   2.88	   1.87	   ±	   1.63	   10	   ±	   1.36	  
L-­‐Alanine	  3TMS_18.93_1361_188?	   0	   ±	   0	   0	   ±	   0	   0	   ±	   0	   3.69	   ±	   4.15	  
L-­‐Threonine	  3TMS_19.60_1387_218	   2.21	   ±	   0.46	   4.56	   ±	   0.73	   3.88	   ±	   1.23	   3.18	   ±	   1.43	  
Erythritol	  4TMS_21.21_1492_217	   0	   ±	   0	   0.78	   ±	   0.08	   0.19	   ±	   0.29	   1.41	   ±	   0.78	  
Malic	  acid	  3TMS_22.01_1484_147	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   3.72	   ±	   0.8	   10	   ±	   2.41	   3	   ±	   2.83	   9.39	   ±	   0.8	  
2-­‐Ketoglutaric	  acid	  2TMS_24.04_1582	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2.38	   ±	   0.44	   4.64	   ±	   1.63	   2.34	   ±	   2.15	   7.93	   ±	   2.96	  
Tryptamine_24.44_1602_188	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   0.72	   ±	   0.26	   0.71	   ±	   0.13	   1.36	   ±	   0.46	   0.67	   ±	   0.12	  
L-­‐Phenylalanine	  2TMS_24.99_1630_218	   0.05	   ±	   0.13	   0.81	   ±	   0.16	   0.15	   ±	   0.26	   0.47	   ±	   0.38	  
Arabitol	  5TMS_26.75_1719_217	   0.06	   ±	   0.05	   0.31	   ±	   0.17	   0.7	   ±	   1.71	   4.47	   ±	   1.41	  
Citric	  acid	  4TMS_28.70_1817_273	  	   2.37	   ±	   0.47	   3.98	   ±	   1.38	   4.89	   ±	   5.12	   8.3	   ±	   1.02	  
Fructose	  5TMS_29.59_1861_103	   0.07	   ±	   0.17	   0.79	   ±	   0.18	   0.4	   ±	   0.99	   1.06	   ±	   0.45	  
Allantoin	  4TMS_29.92_1878_331	   0.99	   ±	   0.68	   8.49	   ±	   3.92	   10	   ±	   2.76	   4.92	   ±	   2.87	  
Mannitol	  6TMS_30.59_1914_319	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2.69	   ±	   0.7	   8.34	   ±	   1.33	   2.42	   ±	   3.36	   10	   ±	   1.61	  
L-­‐Tyrosine	  3TMS_30.91_1933_218	   1.21	   ±	   0.32	   3.58	   ±	   0.73	   1.33	   ±	   0.76	   2.63	   ±	   1.32	  
Gluconic	  acid	  6TMS_31.82_1987_147	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   0.07	   ±	   0.1	   0.15	   ±	   0.14	   0	   ±	   0	   0.37	   ±	   0.11	  
L-­‐Glutamine	  4TMS_31.95_1995_227	   0	   ±	   0	   0	   ±	   0	   0	   ±	   0	   10	   ±	   11.25	  
myo-­‐inositol	  6TMS_32.32_2017_318	  	  	  	  	  	  	  	  	   10	   ±	   1.28	   3.83	   ±	   1.99	   4.46	   ±	   1.58	   6.96	   ±	   1.07	  
Hexdecanoic	  acid	  1TMS_32.83_2048_117	   6.78	   ±	   2.2	   5.39	   ±	   0.96	   3.24	   ±	   0.69	   4.5	   ±	   0.91	  
Octadecanoic	  acid	  1TMS_35.97_2243_117	   4.93	   ±	   1.75	   2.47	   ±	   0.56	   2.9	   ±	   1	   2.37	   ±	   0.37	  
Fructose	  5TMS_29.77_1870_103	   0	   ±	   0	   0	   ±	   0	   0.34	   ±	   0.84	   0.7	   ±	   0.41	  
Lactose	  8TMS_41.93_2670_204	   0	   ±	   0	   0	   ±	   0	   0.13	   ±	   0.33	   0.73	   ±	   0.43	  
Trehalose	  8TMS_42.69_2725_361	  	  	  	  	  	  	  	  	  	  	  	  	  	   10	   ±	   1.06	   0.16	   ±	   0.1	   0.28	   ±	   0.49	   1.02	   ±	   0.32	  
Alternariol	  3TMS_45.58_2959_459	  	  	  	  	  	  	  	  	  	  	  	   1.23	   ±	   0.85	   0	   ±	   0	   0.13	   ±	   0.11	   0.03	   ±	   0.07	  
Ergosterol_48.39_3199_363	   1.64	   ±	   0.75	   5.56	   ±	   1.07	   6.12	   ±	   2.15	   4.59	   ±	   0.63	  
	  
*	  The	  displayed	  metabolites	  each	  showed	  statistically	  significant	  differences	  in	  abundance	  between	  
SN15	  and	  at	  least	  one	  of	  the	  mutant	  strains;	  identified	  in	  bold.	  Metabolite	  abundances	  were	  scaled	  
according	  to	  the	  maximum	  recorded	  abundance	  for	  each	  metabolite,	  across	  all	  measured	  growth	  
conditions,	  which	  was	  scaled	  to	  10;	  underlined.	  Statistical	  significance	  (<0.05)	  was	  determined	  by	  
Tukey-­‐Kramer	  HSD.	  	  
Table	  3.	  The	  fold-­‐change	  in	  metabolite	  abundance	  between	  cultures	  of	  S.	  nodorum	  strains	  gna1-­‐35,	  gba1-­‐6	  and	  
gga1-­‐25	  when	  grown	  under	  non-­‐sporulating22°C	  conditions,	  compared	  to	  the	  same	  strain	  during	  sporulation4°C	  
(6	  weeks	  chilled	  at	  4°C).	  
	  
	  	  	  	  	  	  	  	  	  	  Δ	  Abundance	  
	  Metabolite	  ID	   gna1-­‐35	   gba1-­‐6	   ggaA-­‐25	  
Fumaric	  acid	  2TMS_18.89_1359_245	   ↓1	  4.5	   ↓	  2.36	   ↓	  5.78	  
Malic	  acid	  3TMS_22.01_1484_147	   ↓	  2.07	   ↓	  2.95	   ↓	  2.2	  
Arabinose	  4TMS_25.64_1663_103	   ↓	  ×2	   ×	   ↓	  ×	  
Unknown_29.29_1846_285	   ↓	  ×	   ×	   ↓	  ×	  
Fructose	  5TMS_29.59_1861_103	   ↓	  2.14	   ↓	  1.18	   ↓	  7.07	  
Allantoin	  5TMS_29.79_1871_518?	   ↓	  1.26	   ↓	  1.68	   ↓	  ×	  
Allantoin	  4TMS_29.92_1878_331	   ↓	  2.88	   ↓	  3.98	   ↓	  1.11	  
Mannitol	  6TMS_30.59_1914_319	   ↓	  1.96	   ↓	  1.09	   ↓	  4.22	  
Unknown_35.27_2194_319	   ↓	  63.5	   ↓	  ×	   ↓	  ×	  
Putrescine	  3TMS_21.37_1458_174	   ↑	  ×	   ↑	  ×	   ↑	  ×	  
Tryptamine_24.44_1602_188	   ↑	  11.97	   ↑	  7.35	   ↑	  7.36	  
Unknown_28.85_1824_231	   ↑	  2.14	   ↑	  3.63	   ↑	  1.89	  
Unknown_28.95_1829_147	   ↑	  1.86	   ↑	  2.25	   ↑	  1.22	  
Octadecanoic	  acid	  1TMS_35.97_2243_117	   ↑	  2.47	   ↑	  3.45	   ↑	  3.81	  
Trehalose	  8TMS_42.69_2725_361	   1	   ↑	  1.57	   ↑	  1.24	  
Unknown_52.11_3560_307	   ↑	  8	   ↑	  ×	   ↑	  10.76	  
	  
1	  The	  arrows	  indicate	  whether	  the	  metabolite	  is	  increased	  or	  decreased	  in	  abundance	  under	  sporulating4°C	  
compared	  to	  non-­‐sporulating22°C.	  
2	  The	  ‘x’	  symbol	  indicates	  that	  the	  metabolite	  wasn’t	  present	  in	  either	  the	  non-­‐sporulating22°C	  or	  sporulating4°C	  
samples.	  
	   	  
Table	  4.	  The	  fold-­‐change	  in	  metabolite	  abundance	  between	  cultures	  of	  S.	  nodorum	  strains	  gna1-­‐35,	  gba1-­‐6	  
and	  gga1-­‐25	  when	  grown	  under	  near-­‐sporulating4°C	  conditions	  (3	  weeks	  chilled	  at	  4°C),	  compared	  to	  the	  
same	  strain	  when	  asexually	  sporulating4°C	  (6	  weeks	  chilled	  at	  4°C).	  
	  
	  	  	  	  	  	  	  	  	  	  Δ	  Abundance	  
	  Metabolite	  ID	   gna1-­‐35	   gba1-­‐6	   ggaA-­‐25	  
Arabinose	  4TMS_25.64_1663_103	   ↓1	  ×2	   ↓	  ×	   ↓	  ×	  
Unknown_28.95_1829_147	   ↑	  1.47	   ↓	  1.21	   ↓	  1.9	  
Unknown_29.29_1846_285	   ↓	  ×	   ↓	  ×	   	  	  	  	  	  1	  
Fructose	  5TMS_29.59_1861_103	   ↓	  27.03	   ↓	  11.96	   ↓	  28.8	  
Mannitol	  6TMS_30.59_1914_319	   ↓	  1.96	   ↓	  3.41	   ↓	  1.95	  
Unknown_35.27_2194_319	   ↓	  ×	   ↓	  ×	   ↓	  ×	  
Fumaric	  acid	  2TMS_18.89_1359_245	   ↑	  1.45	   ↑	  3.4	   ↑	  1.29	  
Putrescine	  3TMS_21.37_1458_174?	  	   ↑	  ×	   ↑	  37.04	   ↑	  ×	  
Malic	  acid	  3TMS_22.01_1484_147	   ↑	  1.16	   ↑	  1.8	   ↓	  1.12	  
Tryptamine_24.44_1602_188	   ↑	  26.56	   ↑	  17.54	   ↑	  6.94	  
Unknown_28.85_1824_231	   ↑	  7.3	   ↑	  10.03	   ↑	  5.84	  
Allantoin	  5TMS_29.79_1871_518	   ↑	  ×	   ↑	  ×	   ↑	  ×	  
Allantoin	  4TMS_29.92_1878_331	   ↑	  5.46	   ↓	  1.06	   ↑	  1.09	  
Octadecanoic	  acid	  1TMS_35.97_2243_117	   ↑	  4.76	   ↑	  6.13	   ↑	  3.47	  
Trehalose	  8TMS_42.69_2725_361	   ↑	  1.78	   ↑	  4	   ↑	  3.71	  
Unknown_52.11_3560_307	   ↑	  ×	   ↑	  ×	   ↑	  ×	  
	  
1	  The	  arrows	  indicate	  whether	  the	  metabolite	  is	  increased	  or	  decreased	  in	  abundance	  under	  sporulating4°C	  
compared	  to	  non-­‐sporulating22°C.	  
2	  The	  ‘x’	  symbol	  indicates	  that	  the	  metabolite	  wasn’t	  present	  in	  either	  the	  near-­‐sporulating22°C	  or	  asexually	  
sporulating4°C	  sample.	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